Targeting of a nuclease to murine leukemia virus capsids inhibits viral multiplication.
AUTOR(ES)
Natsoulis, G
RESUMO
Capsid-targeted viral inactivation is an antiviral strategy in which toxic fusion proteins are targeted to virions, where they inhibit viral multiplication by destroying viral components. These fusion proteins consist of a virion structural protein moiety and an enzymatic moiety such as a nuclease. Such fusion proteins can severely inhibit transposition of yeast retrotransposon Ty1, an element whose transposition mechanistically resembles retroviral multiplication. We demonstrate that expression of a murine retrovirus capsid-staphylococcal nuclease fusion protein inhibits multiplication of the corresponding murine leukemia virus by 30- to 100-fold. Staphylococcal nuclease is apparently inactive intracellularly and hence nontoxic to the host cell, but it is active extracellularly because of its requirement for high concentrations of Ca2+ ions. Virions assembled in and shed from cells expressing the fusion protein contain very small amounts of intact viral RNA, as would be predicted for nuclease-mediated inhibition of viral multiplication.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=42740Documentos Relacionados
- Human fetal Schwann cells support JC virus multiplication.
- Infectious viral DNA of murine leukemia virus.
- Establishment of a line of human fetal glial cells that supports JC virus multiplication.
- Viral gene expression in murine sarcoma virus(murine leukemia virus)-infected cells.
- Heparin Binds to Murine Leukemia Virus and Inhibits Env-Independent Attachment and Infection